Skip to content

DR. STIJN VAN WIEMEERSCH

Active Private limited companyfounded 2018active for 8 yearsKlossebos 18, 9052 GhentKBO/BCE: BE 0695.788.720

Lifetime

8 annual accounts with figures on one time axis
peak of €231,842 in 2024
€211,334▼ 8.8%
peak of €84,077 in 2024
€55,958▼ 33.4%
peak of €419,615 in 2025
€419,615▲ 15.4%
€405,548▼ 22.1%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
23-04-20267 days before the deadline
2025micro format
Result from €84,077 to €55,958Equity from €363,656 to €419,615Debts from €520,328 to €405,548

Key points

from the 2025 annual accounts

Equity

€419,615 ▲ 15.4%

DR. STIJN VAN WIEMEERSCH has made a profit in every financial year since 2018.

Investments

€5,080 0.0 times depreciation
2021202220232025

Green is investment, beige is depreciation.

Filings

8 annual accounts since 2018
deadline20202025

The last five annual accounts were filed 0 to 10 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,785 companies had the same profile as DR. STIJN VAN WIEMEERSCH has now. Each dot stands for 17 companies, two years later.

96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,785 companies, not a prediction for DR. STIJN VAN WIEMEERSCH. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Director
  • founderdeed of 11-05-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0695788720
resigns as manager reappointed as director · General meeting of 21-06-2023 · Gazette deed
Incorporation Founding capital of €18,600 · Founded by · appointed as manager · published on 11-05-2018 · Gazette deed
First establishment Klossebos 18, Ghent
All 18 events

Comparable companies

same main activity, similar in size and age
Company
DR. STIJN VAN WIEMEERSCH Ghent €825,162 €211,334 50.9% -
MANNIDOC Sint-Gillis (bij-Brussel) €873,673 €211,482 73.6% -
Dokter Cécile Schockaert, gynaecologie-verloskunde Merchtem €883,058 €223,326 44.8% -
GynCARE Docteurs F. Closon et S. Verscheure Anthisnes €812,545 €228,549 80.5% -
DOKTER SERGOYNE VEERLE, ANESTHESIE BV Merchtem €874,098 €228,855 19.1% -
Patholem Kortrijk €803,395 €239,981 17.3% -
MANEST Waterloo €766,449 €202,560 91.5% -

These companies have the same main activity as DR. STIJN VAN WIEMEERSCH: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €766,000 and €883,000, founded between 2016 and 2019.

Official details

Source: KBO
Status
Active since 08-05-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.275.776.2879052 Ghent, since 08-05-2018
Financial year end
30 September
Peppol
Reachable since 21-10-2026
Company details

Annual accounts to 30-09-2025

≈ €390,000estimated
€825,162▼ 6.7%
Filing
Filed on 23-04-2026, 7 days before the end of the filing period
Financials

Insights on DR. STIJN VAN WIEMEERSCH

DR. STIJN VAN WIEMEERSCH files the micro format. That format states no turnover. The gross margin rose from €185,306 in 2018 to €211,334 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. STIJN VAN WIEMEERSCH

What is the company number of DR. STIJN VAN WIEMEERSCH?
The company number of DR. STIJN VAN WIEMEERSCH is 0695.788.720. The VAT number is the same number with BE in front: BE 0695.788.720.
Where is DR. STIJN VAN WIEMEERSCH based?
The registered office is at Klossebos 18, 9052 Ghent.Company details
What does DR. STIJN VAN WIEMEERSCH do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. STIJN VAN WIEMEERSCH?
DR. STIJN VAN WIEMEERSCH is a private limited company (BV).
When was DR. STIJN VAN WIEMEERSCH founded?
DR. STIJN VAN WIEMEERSCH was founded on 08-05-2018.
Is DR. STIJN VAN WIEMEERSCH still active?
Yes, DR. STIJN VAN WIEMEERSCH is an active enterprise in the KBO register.
What is the turnover of DR. STIJN VAN WIEMEERSCH?
The turnover in financial year 2025 is about €390,000. This figure is estimated from the gross margin of €211,334 and 40 comparable companies (NACE 86220). It probably lies between €330,000 and €520,000.Financials
Is DR. STIJN VAN WIEMEERSCH profitable?
In financial year 2025, DR. STIJN VAN WIEMEERSCH made a profit of €55,958.
Where can I find the annual accounts of DR. STIJN VAN WIEMEERSCH?
DR. STIJN VAN WIEMEERSCH filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. STIJN VAN WIEMEERSCH due?
DR. STIJN VAN WIEMEERSCH must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.